[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Electrophysiology Devices Market 2022 - Industry Briefing

May 2022 | 49 pages | ID: G344F3F0AA94EN
Gen Consulting Company

US$ 1,550.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve atrial fibrillation (AF) treatments, miniaturized diagnostic monitoring systems, and new implantable rhythm management devices that are making procedures much less invasive. Gen Consulting Company predicts that the global electrophysiology devices market is estimated to touch a valuation of USD 15,946 million, registering a CAGR of 8.9% during the forecast period (2022-2028).

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, and region. The global market data on electrophysiology devices can be segmented by product: catheters, electrophysiology (EP) lab devices, others. Electrophysiology devices market is further segmented by region: North America, Asia Pacific, Europe, Rest of the World (ROW).

The catheters market is further segmented into ablation catheters, diagnostic catheters. Furthermore, the EP lab devices market has been categorized into 3D mapping systems, cardiac stimulators, electrophysiology (EP) recording systems, intracardiac echocardiography (ICE) systems, radiofrequency ablation generators.

The global electrophysiology devices market is highly competitive. The leading players in the virtual training and simulation market include Abbott Laboratories, Acutus Medical Inc., AtriCure Inc., Baylis Medical Company Inc., Biosense Webster Inc. (Johnson & Johnson), BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CardioFocus Inc., General Electric Company, Japan Lifeline Co. Ltd., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, OSYPKA AG, Stereotaxis Inc., Vanguard AG.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
  • Get a detailed picture of the Global Electrophysiology Devices Market
  • Identify segments/areas to invest in over the forecast period in the Global Electrophysiology Devices Market
  • Understand the competitive environment, the market’s leading players
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.
Part 1. Summary
Part 2. Introduction
Study period
Geographical scope
Market segmentation
Part 3. Electrophysiology devices market overview
Part 4. Market breakdown by product
Catheters
Electrophysiology (EP) lab devices
Others
Part 5. Market breakdown by region
North America
Asia Pacific
Europe
Rest of the World (ROW)
Part 6. Key companies
Abbott Laboratories
Acutus Medical, Inc.
AtriCure, Inc.
Baylis Medical Company, Inc.
Biosense Webster, Inc. (Johnson & Johnson)
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
CardioFocus, Inc.
General Electric Company
Japan Lifeline Co., Ltd.
Koninklijke Philips N.V.
Lepu Medical Technology (Beijing) Co., Ltd.
Medtronic plc
MicroPort Scientific Corporation
OSYPKA AG
Stereotaxis, Inc.
Vanguard AG
Part 7. Methodology


More Publications